Ubiquitin-Proteasome Pathway Components as Therapeutic Targets for CNS Maladies

E-ISSN： 1873-4286|11|29|3807-3828

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.29, 2005-11, pp. : 3807-3828

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The ubiquitin–proteasome pathway in viral infections

By Gao Guang Luo Honglin

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 1, 2006-01 ,pp. : 5-14

NRC Research Press

Access to resources Recommend Favorite

Emerging Role of the Ubiquitin-proteasome System as Drug Targets

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3175-3189

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Product Inhibitors of the Ubiquitin-Proteasome Pathway

Current Drug Targets, Vol. 12, Iss. 11, 2011-10 ,pp. : 1581-1594

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Degradation by the Ubiquitin-Proteasome Pathway and Organ Fibrosis

Current Medicinal Chemistry, Vol. 19, Iss. 6, 2012-02 ,pp. : 893-900

Bentham Science Publishers

Access to resources Recommend Favorite

Ubiquitin- and proteasome-dependent pathway of protein degradation as an emerging therapeutic target

By Wójcik C.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 89-111

Informa Healthcare

Access to resources Recommend Favorite